Hyaluronidase-3 (HYAL3)

Hyaluronidase-3 (HYAL3) is an enzyme encoded by the human HYAL3 gene and is part of the hyaluronidase family, structurally similar to other hyaluronidases involved in the degradation of hyaluronan, a key glycosaminoglycan in the extracellular matrix[1][7][8]. Although HYAL3 shares homology with other hyaluronidases and is primarily expressed in the testes and bone marrow, its direct enzymatic activity on hyaluronan in humans has not been clearly demonstrated, and it is considered by some sources to primarily act as a non-enzymatic regulator of HYAL1 activity[1][2]. HYAL3 and related hyaluronidases facilitate critical biological processes such as sperm penetration of the cumulus cell layer around the egg. Indirectly, through degradation of hyaluronan or modulation of its turnover, HYAL3 influences extracellular matrix characteristics and can affect cell proliferation, migration, differentiation, and possibly responses to inflammation or tumorigenesis[2][3][4][8]. The HYAL3 gene is located in a chromosomal region associated with tumor suppression (chromosome 3p21.3)[1]. There are no established, clinically approved drugs or biomarkers that specifically target HYAL3, and there are no well-documented safety concerns directly associated with therapeutic targeting of this gene or protein as of current knowledge[1][2][3][7][8].

Other names

Hyaluronidase-3HYAL3LUCA3Hyal-3LuCa-3LUCA-3LUCA14Minna14Hyaluronoglucosaminidase-3Lung carcinoma protein 3hyaluronoglucosaminidase 3lung carcinoma protein 3

Enzyme replacement or inhibition would theoretically block hyaluronan degradation